China Traditional Chinese Medicine Holdings Co (HKSE:00570) COGS-to-Revenue : 0.49 (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

What is China Traditional Chinese Medicine Holdings Co COGS-to-Revenue?

China Traditional Chinese Medicine Holdings Co's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$4,706 Mil. Its Revenue for the six months ended in Dec. 2023 was HK$9,646 Mil.

China Traditional Chinese Medicine Holdings Co's COGS to Revenue for the six months ended in Dec. 2023 was 0.49.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. China Traditional Chinese Medicine Holdings Co's Gross Margin % for the six months ended in Dec. 2023 was 51.21%.

China Traditional Chinese Medicine Holdings Co COGS-to-Revenue Historical Data

The historical data trend for China Traditional Chinese Medicine Holdings Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Traditional Chinese Medicine Holdings Co COGS-to-Revenue Chart

China Traditional Chinese Medicine Holdings Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.40

0.38

0.50

0.49

China Traditional Chinese Medicine Holdings Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.37	0.50	0.49	0.49	0.49

China Traditional Chinese Medicine Holdings Co COGS-to-Revenue Calculation

China Traditional Chinese Medicine Holdings Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	9677.065	/	19821.309
	=	0.49

China Traditional Chinese Medicine Holdings Co's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	4705.861	/	9645.931
	=	0.49

China Traditional Chinese Medicine Holdings Co (HKSE:00570) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

China Traditional Chinese Medicine Holdings Co's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	4705.861 / 9645.931
	=	51.21 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

China Traditional Chinese Medicine Holdings Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of China Traditional Chinese Medicine Holdings Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

China Traditional Chinese Medicine Holdings Co (HKSE:00570) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Traditional Chinese Medicine Holdings Co Ltd (HKSE:00570) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

WSG:Germany

Address

288 Hennessy Road, Room 1601, Emperor Group Centre, Wanchai, Hong Kong, HKG

Website

https://www.china-tcm.com.cn

China Traditional Chinese Medicine Holdings Co Ltd is engaged in the Chinese healthcare sector. The company functions through five segments, finished drugs; concentrated TCM granules; TCM decoction pieces; TCM healthcare complex, and Local TCM integrated operation. It generates maximum revenue from the concentrated TCM granules segment. Geographically, it derives a majority of its revenue from Mainland China.

China Traditional Chinese Medicine Holdings Co (HKSE:00570) Headlines

No Headlines